Apple Tree Partners

Portfolio Co Investors 2026 for Apple Tree Partners: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Apple Tree Partners accounts for 14 tracked companies with verified cap-table data, 14 of which disclose round sizes totalling $923M. The median disclosed raise is $58M, and the largest is Galvanize Therapeutics at $200M, ahead of Shockwave Medical ($100M) and Corvidia ($86M).

The names that recur most often on these co-invested cap tables are Apple Tree Partners (14 companies), Sofinnova Partners (3 companies), Norwest Venture Partners (2 companies), Elevage Medical Technologies (2 companies), Ally Bridge Group (2 companies), Perceptive Xontogeny Venture Fund (2 companies). By latest disclosed round, the market skews Series A (9), Series C (2), Series B (1), Growth (1).

Best funded Apple Tree Partners companies

  1. Galvanize Therapeutics — $200M (latest: Series C)
  2. Shockwave Medical — $100M (latest: Series C)
  3. Corvidia — $86M (latest: Series B)
  4. Limelight Bio — $75M
  5. Akero Therapeutics — $65M (latest: Series A)
  6. Chinook Therapeutics — $65M (latest: Series A)
  7. Aileron Therapeutics — $58M (latest: Growth)
  8. Red Queen Therapeutics — $55M (latest: Series A)
  9. Adendra Therapeutics — $53M (latest: Series A)
  10. Deep Apple Therapeutics — $52M (latest: Series A)
  11. Nereid Therapeutics — $50M (latest: Series A)
  12. Stoke Therapeutics — $40M (latest: Series A)
  13. Aulos Bioscience — $20M (latest: Series A)
  14. Nine Square Therapeutics — $4.5M (latest: Series A)

Apple Tree Partners — related firms and companies (56)

Apple Tree Partners alternatives · All research reports